***SharePad New Subscriber Special Offer***
Readers of my Blog can claim one month of free data. Click now for details.
10 May 2019
By Maynard Paton
For this SharePad search I re-used the screen I employed to pinpoint Victrex.
The filter focuses on two ratios favoured by ‘quality’ investors — operating margin and return on equity (ROE).
This time I selected Abcam, a £2.6 billion AIM company that develops and sells antibodies.
Abcam boasted a super 30% operating margin and a robust 20% ROE.